#United States #Pasadena #Heart Failure #Ventric Health #Vivio System

Ventric Health Launches a Redesigned Experience for Heart Failure Detection

Ventric Health, known for its innovative Vivio® System, has officially launched a revamped website aimed at enhancing the early detection of heart failure. This addition comes at a critical time, as the medical community grapples with the challenge of accurately diagnosing heart failure in its initial stages. The newly designed platform at ventrichealth.com strengthens the support available to healthcare professionals, particularly primary care doctors and cardiologists.

The common scenario in heart failure diagnosis reveals that about 65% of at-risk individuals receive their first diagnosis only in emergency or inpatient settings, often 30 months after symptoms begin. This delay leads to significantly increased health care costs — approximately $21,800 per patient annually for late-stage management, compared to just $4,300 for early intervention. By fostering a quicker and more efficient diagnosis process within primary care practices, Ventric Health aims to improve patient outcomes, enhance quality of life, and reduce overall healthcare expenditures.

The redesigned website offers a user-friendly interface packed with features tailored to meet the needs of its users:

• - Expanded Resource Hub: Users can access peer-reviewed research and workflow guidelines tailored to both clinical and administrative leaders, helping them navigate heart failure management more effectively.
• - Stages of Heart Failure Breakdown: The site includes educational content that illustrates the progression of heart failure, empowering healthcare providers with knowledge to recognize its early signs.
• - Streamlined Demo Requests: Potential users can easily request a demonstration of the Vivio® System, with clear outlines of what they can expect during a 45-minute session.
• - In-Depth FAQs: Enhanced content detailing the real-world implementation of the Vivio System, addressing common inquiries to ensure users are well-informed.

‘This new website reflects our commitment to giving healthcare systems the information they need to act on heart failure earlier,’ remarks Dr. Thomas Cheek, Chief Medical Officer at Ventric Health. His statement underlines the company's dedication to bridging the diagnostic gap present in heart failure management.

Understanding the Vivio® System

The Vivio® System is a groundbreaking non-invasive device approved by the FDA, designed to measure elevated left ventricular end-diastolic pressure (LVEDP) in outpatient settings. By utilizing a physics-based analysis of cardiac pressure and volume waveforms, this system enables healthcare providers to obtain results quickly, often within five minutes, thus eliminating the need for imaging, referrals, or invasive procedures. The test combines objective physiological data with the Kansas City Cardiomyopathy Questionnaire (KCCQ-12), presenting a comprehensive clinical picture of the patient’s heart health.

Evidence published in earlier studies, including a 2025 multicenter JAHA validation study, reinforces the efficacy of the Vivio System in various clinical settings, showcasing impressive outcomes in pre-symptomatic Stage A detection and primary care screening findings reported in JACC Advances.

About Ventric Health

Ventric Health is dedicated to the advancement of earlier heart failure detection through the Vivio® System, a device now trusted by various leading health systems and Medicare ACOs across the United States. The company’s headquarters is located in Pasadena, California, where it continues to innovate in the field of cardiac health.

Ventric Health is committed to providing healthcare practices with the tools they need to improve patient care, making strides in the fight against heart failure through better early detection and patient management strategies.